Mexat®
Methotrexate USP Injection
Brand Name:
Mexat®50
Generic Name:
Methotrexate
Strength:
50mg/2mL
Description:
Liquid injection
Pack Size:
1's
* Storage Conditions: Store below 30 °C temperature. Keep away from light and wet place. Keep out of reach of children.
Approved Indications of Mexat
- Choriocarcinoma: Methotrexate – as single chemotherapy or in combination with other drugs.
- Intermediate-, or high-grade Non-Hodgkin's Lymphoma as part of ProMACE-CytaBOM, ProMACE-MOPP, and Magrath protocols.
- Breast Cancer: as part of CMF (cyclophosphamide-methotrexate- uorouracil) therapy.
- Acute Lymphoblastic Leukemia: as maintenance therapy.
- Head and Neck Cancer: in combination with other chemotherapies.
- Gastric Cancer: palliative combination chemotherapy.
- Metastasis of unknown primary: as palliative combination chemotherapy.
- Bladder Cancer (advanced): as part of the M-VAC Regimen.
- Burkitt's lymphoma.
- Advanced stages of childhood lymphoma (III and IV, St. Jude's Children’s' Research Hospital Staging System).
- Advanced cases of mycosis fungoides (cutaneous T-cell lymphoma).